ダウンロード数: 1106

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
63_5_201.pdf935.58 kBAdobe PDF見る/開く
タイトル: CTガイド下生検およびMTX投与歴からMTX関連リンパ増殖性疾患と診断しえた両側副腎偶発腫瘍の1例
その他のタイトル: A Case of Bilateral Adrenal Incidentaloma in which MTX-Related Lymphoproliferative Disease Could Be Diagnosed by Computed Tomography-Guided Biopsy and MTX Administration History
著者: 北風, 宏明  KAKEN_name
松下, 慎  KAKEN_name
岡田, 紘一  KAKEN_name
湊, のり子  KAKEN_name
森, 直樹  KAKEN_name
吉岡, 俊昭  KAKEN_name
著者名の別形: Kitakaze, Hiroaki
Matsushita, Makoto
Okada, Koichi
Minato, Noriko
Mori, Naoki
Yoshioka, Toshiaki
キーワード: Adrenal glands
Adrenal incidentaloma
Methotrexate-associated lymphoproliferative disorder (MTX-LPD)
CT guided biopsy
Diffuse large B-cell lymphoma
発行日: 31-May-2017
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 63
号: 5
開始ページ: 201
終了ページ: 206
抄録: The patient was a 76-year-old man. Because bilateral adrenal tumor (right adrenal gland 7 cm, left adrenal gland 1.5 cm) was detected in by computed tomography (CT) in methotrexate (MTX) administration for articular rheumatism from 2011, he was referred to this hospital in February, 2016. An endocrine examination, and imaging study did not lead to a definitive diagnosis and CT-guided lower needle biopsy was performed. The pathological diagnosis was diffuse large B cell lymphoma. Also, in situ hybridization revealed EBER-positive and the diagnosis of MTX-related lymphoproliferative disease (MTXLPD) was made in conjunction with the medical history. After MTX cancellation, the tumor became markedly smaller. The annual incidence of this disorder in the RA patients during MTX internal use is reported as 0.06%. According to the site of origin, lymphatic extranodal disease accounts for approximately half of the cases, but this is the third case of primary adrenal origin reported.
著作権等: 許諾条件により本文は2018/06/01に公開
DOI: 10.14989/ActaUrolJap_63_5_201
URI: http://hdl.handle.net/2433/226073
PubMed ID: 28625027
出現コレクション:Vol.63 No.5

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。